# Association of Immune Related Adverse Events With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Cancers: A Systemic Review and Meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/association-of-immune-related-adverse-events-with-efficacy-of-immune-checkpoint/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yong Fan,Wenhui Xie,Hong Huang,Yunxia Wang,Guangtao Li,Yan Geng,Yanjie Hao,Zhuoli Zhang |
| Citations | 112 |
| DOI | 10.3389/fonc.2021.633032 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fonc.2021.633032/pdf |
| OpenAlex ID | https://openalex.org/W3155812430 |
| PMID | 33912454 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Hong Huang](https://scholariq.org/researchers/hong-huang/)

## Paper journal

- [Frontiers in Oncology](https://scholariq.org/journals/frontiers-in-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Multiple and Secondary Primary Cancers](https://scholariq.org/topics/multiple-and-secondary-primary-cancers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.